US2014363408A1PendingUtilityA1
Extracellular matrix from pluripotent cells
Est. expiryDec 3, 2027(~1.4 yrs left)· nominal 20-yr term from priority
Inventors:Irina Aizman
A61P 25/00C12N 2510/00A61K 2035/124A61K 35/12C12N 5/0622A61K 35/28C12N 2501/42C12N 2533/90C12N 5/0663C12N 5/0619
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Isolated extracellular matrix from marrow adherent stromal cells and their descendents, which stimulates the growth and survival of a number of different neural cell types, is provided, along with methods for preparation and uses.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for producing an exogenous extracellular matrix in a subject, the method comprising transplanting a population of differentiation-restricted descendants of marrow adherent stromal cells (DRCs) to a site in the subject.
2 . The method of claim 1 , wherein the DRCs are made by transfecting marrow adherent stromal cells with a nucleic acid comprising sequences encoding a Notch intracellular domain.
3 . The method of claim 1 , wherein the exogenous extracellular matrix stimulates growth of neurons in the subject.
4 . The method of claim 1 , wherein the exogenous extracellular matrix stimulates growth of astrocytes in the subject.
5 . The method of claim 1 , wherein the exogenous extracellular matrix stimulates growth of oligodendrocytes in the subject.
6 . The method of claim 1 , wherein the exogenous extracellular matrix is a source of matrix-bound growth factors.
7 . The method of claim 6 , wherein the matrix-bound growth factors serve as chemotactic and/or haplotactic stimuli for neurons and glia.
8 . The method of claim 1 , wherein the exogenous extracellular matrix supports survival of neurons and/or glial cells in the subject.
9 . The method of claim 1 , wherein the exogenous extracellular matrix supports proliferation of neurons and/or glial cells in the subject.
10 . The method of claim 1 , wherein the exogenous extracellular matrix supports neurite outgrowth in the subject.
11 . The method of claim 1 , wherein the site is in the central nervous system.
12 . The method of claim 1 , wherein the site is in the peripheral nervous system.
13 . The method of claim 1 , further comprising transplanting marrow adherent stromal cells to the site.
14 . The method of claim 1 , wherein an isolated extracellular matrix is co-transplanted with the DRCs.
15 . The method of claim 14 , wherein the isolated extracellular matrix is produced by a DRC.
16 . The method of claim 14 , wherein the isolated extracellular matrix is produced by a marrow adherent stromal cell.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.